Introduction terations were limited to leukemia of myeloid lineage, recent studies have demonstrated that AML1 is freThe investigation of leukemia-associated translocations quently mutated in pediatric B progenitor acute lymphhas provided insights into the mechanisms of transforoblastic leukemia (ALL), the most common malignancy mation in human leukemia and has led to the identificaseen in children (Pui, 1995) . Cloning of the ALL-assocition of a series of transcription factors implicated in ated t(12;21) revealed the formation of a chimeric gene the regulation of normal hematopoiesis (Rabbitts, 1994) .
that encoded a fusion protein consisting of the N-termiThe most frequent target of these translocations is the nal helix-loop-helix domain of TEL, a member of the Etsacute myeloid leukemia 1 (AML1)-core-binding factor ␤ like family of transcription factors, fused to nearly the (CBF␤) heterodimeric transcription factor complex (Miycomplete AML1 protein, including the RHD and C-termioshi et Erickson et al., 1992; Nisson et al., nal domains (Golub et al., 1995; Romana et al., 1995a ). 1992; Nucifora et al., 1993; Mitani et al., 1994; Golub et Analysis of a large number of pediatric ALL cases demal., 1995; Liu et al., 1993) . AML1 is a member of a family onstrated expression of the TEL-AML1 chimeric tranof transcription factors with homology to the Drosophila script in ‫%52ف‬ of cases with a B progenitor immunopair-rule gene runt and directly binds the enhancer core phenotype, despite the complete lack of cytogenetic DNA sequence TGT/cGGT, which is present in a number evidence of this translocation in the majority of cases of different viral and cellular promoters and enhancers (Romana et al., 1995b; Shurtleff et al., 1995b) . Thus, (Daga et al., 1992; Erickson et al., 1992; taken together, these data suggest that alteration of al., Meyers et al., 1993; Manley et al., 1993) . AML1 transcriptional cascades mediated by AML1 is one of the binds DNA via a central 118 amino acid Runt homology most common mechanisms of transformation in human domain (RHD), and its DNA binding affinity is increased leukemia. by heterodimerization through the RHD with CBF␤ (Mey-AML1 binds the enhancer core motif that is present ers et al., Wang et al., 1993; Ogawa et al., 1993a) .
in the transcriptional regulatory region of a number of AML1 was identified through its involvement in the different hematopoietic-specific genes, including the T AML-associated t(8;21), which occurs in ‫%51ف‬ of de cell antigen receptors (Prosser et al., 1992 ; Redondo et novo cases (Miyoshi et al., 1991) . In this translocation, al., 1992; Wang et al., 1993; Hsiang et al., 1993) , the AML1, including its RHD, fuses to a zinc fingermyeloid-specific gene myeloperoxidase (Nuchprayoon containing putative transcription factor, ETO, on chroet al., 1994) , and a variety of cytokines and their remosome 8 to form an AML1-ETO chimeric product (Erceptors, including granulocyte-macrophage colonystimulating factor (GM-CSF) (Takahashi et al., 1995 (Shoemaker et al., 1990) , and the colony-stimulating factor 1 (CSF1) receptor (Zhang et al., 1994) . The enhancer core motif is necessary for the tissue-specific expression of these genes, but cannot confer tissue specificity to a heterologous promoter. In addition, this sequence is in the enhancers of the simian virus 40 (Weiher et al., 1983) , polyoma virus (Kamachi et al., 1990) , and all murine type C retroviruses (Manley et al., 1993; Sun et al., 1993) and has been shown to represent a critical regulatory region in several murine leukemia retroviral enhancers, where it influences tissue tropism and disease phenotype (Boral et al., 1989; LoSardo et al., 1990; Speck et al., 1990) . Thus, AML1 may function as a transcriptional organizer that recruits tissue-specific factors to stimulate lineage-restricted transcription. Moreover, recent data suggest that AML1-mediated transcriptional activity of cellular genes is dependent on sequences adjacent to the enhancer core motif, with activity only detected using enhancers or promoters bearing Ets-1-or c-Myb-binding sites near the AML1 site (Hernandez-Munain and Krangel, 1995; Wotton et al., 1994) .
Cloning of murine CBF and polyoma enhancer-binding protein (PEBP2) (Ogawa et al., tected in all adult tissues, with the highest levels of could be distinguished by Southern blots of XbaI-digested DNA, expression seen in the thymus, bone marrow, and pehybridized with either the indicated 5Ј or 3Ј probes. (B) Southern blot analysis of ES cell clones and E11.5 embryos from ripheral blood (Zhu et al., 1994;  an AML1 ϩ/Ϫ intercross. ES cell clones with homologous targeting Miyoshi et al., 1995 Although the available data suggests that AML1 is likely to play a pivotal role in the regulation of target codons are introduced into all three reading frames, and genes involved in the function of the hematopoietic linthus any AML1 protein formed will lack the RHD and eages, its normal cellular functions remain to be defined.
will be unable to bind DNA or to interact with CBF␤. To investigate directly the normal biologic function of Following electroporation of the targeting construct, ES AML1 in vivo, we generated mice carrying a disrupted cell clones were grown in the presence of hygrB and AML1 allele using gene targeting in embryonic stem ganciclovir (GANC), and double-resistant clones were (ES) cells. Mice lacking AML1 died during midembryonic analyzed by Southern blotting to screen for homologous development secondary to the complete absence of recombinants ( Figure 1B ). Of the 80 hygrB R /GANC R E14 fetal liver-derived hematopoiesis. Moreover, homozy-ES clones obtained, 20 (25%) contained a correctly targous AML1-deficient ES cells failed to contribute to hegeted AML1 allele. Two independently targeted clones matopoiesis in chimeric animals. These findings indicate with normal ploidy were injected into C57BL/6 blastothat AML1-regulated target genes are essential for defincysts and gave germline transmission. F1 mice heteroitive hematopoiesis of all lineages.
zygous for the AML1 mutation appeared normal and had no discernible differences when compared with wild-type littermates in their hematocrits, nucleated Results blood cell counts, white blood cell differentials, or distribution of peripheral blood lymphocyte subsets as anaTargeted Disruption of AML1 Results in an Embryonic Lethal Phenotype in Mice lyzed by fluorescence-activated cell sorting analysis (data not shown). Heterozygous mice were interbred The AML1 gene was inactivated using a replacement vector designed to disrupt the coding sequence of AML1 to generate homozygous mutants, and among the 161 newborn offspring genotyped, no AML1 Ϫ/Ϫ mice were by replacing the splice acceptor and first 20 bp of the exon that encodes the central 52 amino acids of the identified, indicating that loss of AML1 is incompatible with normal embryonic development (Table 1) . RHD with a hygromycin B (hygrB) cassette ( Figure 1A) . As a consequence of this targeting strategy, termination
To confirm that gene targeting into the AML1 locus showed no overt evidence of anemia. Small foci of intra- Detailed microscopic analysis of the yolk sac of E11.5 embryos revealed no significant morphologic differences between AML1-deficient and control embryos had resulted in an inactivating mutation, reverse tran-(data not shown). During normal murine embryonic descriptase-polymerase chain reaction (RT-PCR) analysis velopment, the major site of hematopoiesis shifts from for AML1 transcripts was performed on poly(A) ϩ RNA the yolk sac to the fetal liver at around E11.5-E12.5. isolated from viable embryonic day 11.5 (E11.5) whole
Microscopic examination of the livers of AML1-deficient embryos. Amplification of AML1 mRNA was with a set embryos at E11.5 revealed the complete absence of of AML1-specific oligonucleotide primers that bracket fetal liver-derived hematopoiesis. No erythroid, myeloid, the position of the hygrB cassette insertion, and PCR or megakaryocyte elements were identified in sections products were probed with an AML1-specific oligonuof AML1 Ϫ/Ϫ livers, with only primitive nucleated erythrocleotide after Southern blot transfer. As shown in Figure  cytes seen within vascular channels and hepatic sinu-2, no amplifiable AML1 mRNA was detected in the soids ( Figure 4A ). Moreover, analysis of impression AML1 Ϫ/Ϫ embryos, whereas this mRNA was observed smears made from livers of AML1 Ϫ/Ϫ embryos confirmed in control littermates. Thus, the targeting strategy the lack of hematopoietic cells ( Figure 4B ). In addition, used resulted in elimination of AML1 mRNA encoding peripheral blood of the AML1-deficient embryos at both the RHD.
E11.5 and E12.5 contained only nucleated large primitive To identify the stage of embryonic development at erythrocytes, consistent with a yolk sac origin, and which the AML1 mutation is lethal, E10.5-E13.5 embryos lacked identifiable platelets, which were clearly visible were analyzed. At E11.5 the majority of AML1-deficient in blood smears from wild-type and heterozygous litembryos (87%) were viable; however, by E12.5, very few termates ( Figure 4C ).
AML1
Ϫ/Ϫ embryos were found alive (Table 1) . MorphoThe observed hematopoietic defect in AML1 Ϫ/Ϫ emlogic evaluation of embryos at E12.5 revealed extensive bryos suggests that yolk sac-derived primitive hematohemorrhages within the ventricle of the central nervous poiesis was unaffected, but that there was a complete system and vertebral canal ( Figures 3A and 3B ). Death block in the establishment of fetal liver-derived definitive appeared to occur shortly before or during embryo dishematopoiesis. To examine the hematopoietic activity section, since mutant embryos were comparable in size further, we isolated individual yolk sacs and fetal livers and development to their wild-type and heterozygous from mutant and control embryos and analyzed them littermates. Microscopically, the hemorrhages in the mufor in vitro hematopoietic colony formation. Yolk sacs tant animals appeared to originate within the ganglia of obtained from viable E10.5 embryos were dispersed into the cranial nerves and extended into the third and lateral single cell suspensions and cultured in triplicate in 1.2% ventricles. In addition, hemorrhages occurred within the methylcellulose in media containing 30% fetal calf sepericardial space and peritoneal cavity in the majority rum (FCS) supplemented with human erythropoietin and of AML1-deficient animals ( Figure 3C ; data not shown).
containing murine stem cell factor, IL-3, and GM-CSF. At E11.5, viable AML1 Ϫ/Ϫ animals were morphologiThese conditions are optimal for the differentiation of cally indistinguishable from their littermates except for multipotential hematopoietic progenitor cells with coloa slight pallor to the liver (see below). The yolk sac nies being of definitive hematopoietic origin, since at vessels were easily visualized, and the mutant embryos this stage of development, no primitive hematopoietic progenitors are detected in yolk sacs (Wong et al., 1986) . No hematopoietic colonies of any lineage grew in the yolk sac cell cultures from AML1-deficient embryos, whereas 473 Ϯ 132 and 525 Ϯ 74 total colonies per yolk sac were detected in cultures from wild-type and heterozygous littermates, respectively (Table 2) . Similarly, hematopoietic progenitors were completely absent in E11.5 fetal liver cultures from AML1-deficient embryos, but were readily detected in essentially equal numbers in cultures from wild-type and heterozygous and liver. These data suggest that loss of AML1 function results either in an intrinsic defect in stem cells or multicell clones with normal ploidy and single vector inserpotential progenitors responsible for establishing definitions in the targeted AML1 alleles and three nonhomolotive hematopoiesis or in a defect in the yolk sac and gous recombinants (AML1 ϩ/Ϫ ES cell clones) with only fetal liver microenvironment that prevents normal in vivo random integrations of the second targeting vector were development of these cells.
selected for in vitro and in vivo differentiation studies. The hematopoietic differentiation capacity of these ES cell lines were assayed by culturing them in vitro as AML1 Ϫ/Ϫ ES Cells Differentiate into Primitive embryoid bodies. When ES cells are cultured as emErythrocytes In Vitro, but Fail to Contribute bryoid bodies, cells of both the myeloid and erythroid to Hematopoietic Lineages In Vivo series develop, and the erythroid cells express embryTo define further the hematopoietic defect induced by onic hemoglobins and thus represent primitive erythroloss of AML1, we generated ES cells with both AML1 poiesis (Wiles and Keller, 1991) . Analysis of 8-to alleles disrupted. An AML1 ϩ/Ϫ ES cell clone was sub-10-day-old ES cell cultures from both control and AML1-jected to a second round of gene targeting using the deficient ES cells revealed numerous hemoglobinized replacement vector pKO4-4-neo, which was similar to embryoid bodies that contained nucleated erythrocytes that used in the initial targeting of AML1 except that the ( Figure 5 ). Thus, AML1-deficient ES cells retain the abilhygrB R gene was replaced by a neomycin resistance ity to undergo primitive erythroid differentiation in vitro. (neo R ) coding sequence. AML1 ϩ/Ϫ ES cells were electroBy contrast, after 16 days in culture no monocytes or porated with this construct and selected in media conmacrophages were seen in the embryoid bodies from taining hygrB, G418, and GANC, and triply resistant AML1-deficient cells, whereas numerous differentiated clones were analyzed by Southern blotting for evidence monocytes were present in the control cultures. These of homologous recombination. Results of this analysis data suggest that under these in vitro conditions, loss revealed that 20% of triply resistant clones had underof AML1 also impairs monocytic differentiation. gone targeted inactivation of the wild-type allele. jected into blastocysts, and chimeric animals were anain their ability to contribute to definitive hematopoiesis and that this deficit is intrinsic to hematopoietic stem lyzed for the contribution of the ES cells to the tissues of the mouse. The relative contribution of AML1 Ϫ/Ϫ and cells or multipotential progenitors.
ϩ/Ϫ ES cells to chimeric animals, as estimated by agouti coat color, was similar and typically ranged from 50% to 90%. The extent of contribution of the injected Discussion ES cells to individual organs was determined by use of glucose phosphate isomerase (GPI) isoform analysis Molecular analyses of leukemia-associated chromosomal rearrangements have indicated that the genes (Williams et al., 1994) . The E14 ES cells contain the GPI-1A isoform, whereas the C57BL/6 cells of the host encoding the AML1-CBF␤ transcription factor complex are the most frequent target of translocations and inverembryo are GPI-1B isoform specific. We examined 13 different tissues from 1-month-old chimeric mice, and sions in human leukemia (for reviews see Nucifora and Rowley, 1995; Liu et al., 1995; Meyers and Hiebert, 1996) . representative results are illustrated in Figure 6 . AML1
Ϫ/Ϫ
ES cells failed to contribute to bone marrow, spleen, AML1-CBF␤ directly binds the enhancer core motif and has been shown to regulate expression of a variety of thymus, or peripheral blood, whereas they had considerable contribution to all of the nonhematopoietic organs hematopoietic specific genes, suggesting that it is likely to play an important role in normal hematopoietic develexamined. By contrast, AML1 ϩ/Ϫ ES cells contributed to all tissues, including sites of hematopoiesis. These data opment (Meyers and Hiebert, 1996) . Using AML1-deficient mice, we now demonstrate that expression of suggest that AML1 Ϫ/Ϫ ES cells have a selective defect Takahashi et al., 1995) and the growth factor receptor for CSF1 (Zhang et al., 1994) ; however, it is unlikely that the loss of expression of any of these genes is mechanistically involved in the observed phenotype.
Mice carrying a targeted mutation in the GM-CSF gene is the underlying defect in osteopetrotic (op/op) mice (Yoshida et al., 1990) . These animals are characterized by impaired mononuclear phagocyte development and AML1 is essential for the establishment of definitive hea deficiency of osteoclasts that results in an increase matopoiesis of all lineages. AML1-deficient embryos in bone density and occlusion of the marrow cavity. showed normal morphogenesis and had active yolk sacMoreover, mice with mutations in both the GM-CSF and derived primitive erythropoiesis; however, they lacked CSF1 genes present with features corresponding to definitive hematopoietic progenitors in both the yolk sac mice deficient in either factor alone, with the predomiand fetal liver and failed to develop fetal liver hematopoinant hematopoietic defect being a deficiency of mature esis. As a result of this hematopoietic defect, the macrophages . Similarly, IL-3 is AML1 Ϫ/Ϫ embryos died during midembryonic developnot thought to play a major role in the regulation of ment, secondary to hemorrhages within the brain, periembryonic hematopoietic stem cells and is expressed cardium, and peritoneum that presumably resulted from primarily by activated T cells, which appear well after an absence of circulating platelets, compounded by an establishment of fetal liver hematopoiesis (for review see apparently evolving anemia resulting from an inability Ihle, 1992) . Therefore, it is likely that additional AML1-to produce definitive nonnucleated erythrocytes. Moreregulated target genes remain to be identified and that over, the underlying hematopoietic defect resulting from these target genes will function as components in signal the loss of AML1 was cell autonomous in that AML1 Ϫ/Ϫ transduction pathways critical for the normal survival, ES cells failed to contribute to any hematopoietic tissues proliferation, or differentiation of hematopoietic stem in the normal microenvironment of chimeric mice.
The presence of normal primitive yolk sac hematopoicells that are responsible for establishing definitive heesis along with the complete absence of fetal livermatopoiesis. The phenotype resulting from the loss of AML1 is distinct from the consequences of targeted mutations in a number of other genes implicated in hematopoietic development (Orkin, 1995) . Mice with null mutations in either tal1/SCL (Shivdasani et al., 1995) or rbtn2 (Warren et al., 1994) die during early embryonic development from severe anemia that results from the complete absence of primitive yolk sac-derived erythropoiesis. Similarly, GATA1-deficient ES cells do not contribute to primitive erythropoiesis in chimeric animals or in vitro (Pevny et al., 1991; Simon et al., 1992; Weiss et al., 1994) . By contrast, mutations in GATA2 lead to an early embryonic definitive erythropoiesis (Tsai et al., 1994) . Homozygous loss of c-myb, like AML1, results in normal yolk sac-derived erythropoiesis, but a severe defect in could in part be the result of noncritical functions for AML1 in these tissues, or, alternatively, its function is fetal liver hematopoiesis (Mucenski et al., 1991) . The redundant and can be complemented by other AML1 major difference from the phenotypic consequences family members. Along these lines, it is curious that resulting from the loss of AML1 is that livers from bleeding appears to initiate within the cranial nerve ganc-myb-deficient mice retain hematopoietic progenitors, glia of the AML1-deficient embryos. Either these strucalthough at markedly reduced numbers compared to tures are uniquely susceptible to bleeding at this stage controls. In addition, mice lacking c-myb have normal of embryonic development or AML1 provides an essenmegakaryocytic development and hence do not die from tial function within these cells. No morphologic abnorbleeding, but succumb to complications of anemia malities were observed in cells of the nervous system somewhat later in development. Similarly, loss of PU.1, of the AML1-deficient mice, and thus we are unable at a member of the Ets-like family of transcription factors, present to address this latter issue. Detailed analysis of results in impaired fetal liver hematopoiesis; however, the expression pattern of AML1, AML2, and AML3 during this defect also appears to spare megakaryocytes and embryogenesis in both wild-type and mutant animals to be less severe in the erythroid lineage (Scott et al., should help to clarify these questions. 1994). These mice die from anemia at an even later stage In summary, our results demonstrate that the AML1-of development than the c-myb-deficient mice. The CBF␤ transcription factor complex plays a pivotal role close relationship among the phenotype of mice that in regulating the transcription of genes that are essential lack AML1, c-myb, or PU.1 is interesting given that AML1 for definitive hematopoiesis. The frequent targeting of cooperates with c-Myb-and Ets-like family members this complex by leukemia-associated chromosomal rein regulating the tissue-specific expression of several arrangements suggests that alteration of its activity hematopoietic-specific genes (Wotton et al., 1994; Her- leads to the disruption of AML1-mediated signals, which nandez- Munain and Krangel, 1995) . It is likely that AML1, are critical for normal growth control or differentiation. c-Myb, and Ets-like proteins coordinately regulate parWe speculate that AML1 functions as a master switch tially overlapping sets of genes. The observed phenothat controls the ability of hematopoietic stem cells to types suggest that target genes regulated by AML1 apdifferentiate into definitive hematopoietic elements. Alpear to be essential for the development of definitive terations in its activity may result in a block in differentiahematopoiesis of all lineages, whereas c-Myb and PU.1 tion that leads to an increase in proliferating hematopoitarget genes are necessary in a more restricted set of etic progenitors that are prone to acquire secondary lineages.
mutations that eventually result in malignant transforMore recently, targeted disruption of the GATA3 tranmation. scription factor was shown to result in a phenotype that is, in part, similar to that seen in the AML1 Ϫ/Ϫ embryos (Pandolfi et al., 1995) . GATA3-deficient embryos die be-
Experimental Procedures
tween E11 and E12 from massive internal bleeding and
Construction of AML1 Targeting Vectors
have markedly suppressed fetal liver hematopoiesis;
To construct pKO4-4-hygrB, overlapping AML1 genomic clones however, these mice display normal yolk sac definitive were isolated from a phage library made from strain 129-derived hematopoiesis, and their fetal livers contain erythroid CCE ES cell DNA (van Deursen et al., 1992) , and an 8 kb fragment precursors and normal megakaryocytes. In addition, containing exon 4 was subcloned into pBluescript (Stratagene). A 2 kb hygrB R cassette (van Deursen et al., 1991) The fact that loss of AML1 resulted in a phenotype pRC/RSV (Invitrogen). This substitution introduced an XbaI restriction site, 5Ј to the neo R cassette, which was used to discriminate confined to the hematopoietic system at E12.5 was leads to segmentation defects and lethality (Gergen and pKO4-4-hygrB or pKO4-4-neo, was electroporated into 1.5 ϫ 10 7 Wieschaus, 1985; Gergen and Wieschaus, 1986) . In ad-ES cells in 2 ml of phosphate-buffered saline (PBS) at 230 V and 500 F. Selection was initiated 24 hr later by adding 90 U/ml hygrB dition, it has been shown to function in Drosophila sex (Calbiochem) and 2 M GANC (Syntex) or, in the second round of determination and neural development (Duffy and Gertargeting, by the further addition of 125 g/ml G418 (GIBCO BRL), gen, 1991; Kania et al., 1990) . Moreover, murine AML1
and selection was continued for 8 days. Doubly or triply resistant is widely expressed in a large number of tissues and clones were analyzed by Southern blot analysis for evidence of cell types (Miyoshi et al., 1995) . The absence of a more homologous recombination. Southern blots of XbaI-digested genomic DNA were hybridized with a 0.4 kb 5Ј or a 0.5 kb 3Ј AML1
widespread phenotype in the AML1-deficient mice genomic fragment that corresponded to genomic sequences out-300 V at 4ЊC. Following electrophoresis, membranes were stained with 10 ml of a 0.9% agarose solution that contained 5 mM magside of the vector. ES cell clones with normal karyotypes were used for injections into C57BL/6 blastocysts. Male chimeras were bred nesium acetate, 15 mg of fructose-6-phosphate, 2 mg of methylthiazolium tetrazolium, 0.36 mg of phenazine methosulfate, 2 mg of with C57BL/6 females, and germline transmission of the ES cellderived genotype was assessed by coat color. Tail biopsies of agouti nicotinamide adenine dinucleotide phosphate, and 10 U of glucose-6-phosphate dehydrogenase, and bands appeared in 10-15 min offspring were screened for the disrupted AML1 gene by Southern blot analysis as previously described (Okuda et al., 1995) . (Williams et al., 1994) .
RT-PCR Analysis

